Research output per year
Research output per year
Personal profile
Headline
PROFESSOR | Medicine, Hematology and Medical Oncology PROFESSOR | Urology
Biography
Specialty Hematology-Oncology Certifications Medical Oncology Clinical Focus Bladder Cancer Kidney Cancer Primary Pulmonary Hypertension Prostate Cancer Testicular Tumors Urologic Cancers Education Residency, Internal Medicine Beth Israel Deaconess Medical Center- Harvard Medical School Fellowship, Medical Oncology Memorial Sloan-Kettering Cancer Center Biography Dr. Galsky specializes in the care of patients with genitourinary malignancies (bladder, prostate, kidney, and testicular cancers). His research focuses on the development of novel treatments for these cancers and he has published extensively in this area. He serves as Director of Genitourinary Medical Oncology at the Tisch Cancer Institute. Awards 2003 - American Society of Clinical Oncology Merit Award 1998 - Medical Calss of 1928 Award (Tufts School of Medicine, Excellence in Anatomy) 1998 - Leon Levinson Prize (Tufts School of Medicine, Excellence in Physiology) 1997 - Alpha Omega Alpha Honor Society
Fingerprint
Dive into the research topics where Matthew Galsky is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274
Galsky, M. D., Witjes, J. A., Gschwend, J. E., Milowsky, M. I., Schenker, M., Valderrama, B. P., Tomita, Y., Bamias, A., Lebret, T., Shariat, S. F., Park, S. H., Agerbaek, M., Jha, G., Stenner, F., Ye, D., Giudici, F., Dutta, S., Askelson, M., Nasroulah, F. & Zhang, J. & 2 others, , 1 Jan 2025, In: Journal of Clinical Oncology. 43, 1, p. 15-21 7 p.Research output: Contribution to journal › Article › peer-review
9 Scopus citations -
An evaluation of nivolumab plus gemcitabine and cisplatin in the treatment of advanced urothelial carcinoma
Miller, E. J. & Galsky, M. D., 2025, In: Expert Review of Anticancer Therapy. 25, 4, p. 319-326 8 p.Research output: Contribution to journal › Review article › peer-review
-
Association of Tumor-informed Circulating Tumor DNA Detectability Before and After Radical Cystectomy with Disease-free Survival in Patients with Bladder Cancer
Sfakianos, J. P., Basu, A., Laliotis, G., Cumarasamy, S., Rich, J. M., Kommalapati, A., Glover, M., Mahmood, T., Tillu, N., Hoimes, C. J., Selig, G., Kollipara, R., Stewart, T. F., Rivero-Hinojosa, S., Dutta, P., Calhoun, M., Sharma, S., Malhotra, M., ElNaggar, A. C. & Liu, M. C. & 7 others, , 1 Apr 2025, In: European urology oncology. 8, 2, p. 306-314 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer
Daneshmand, S., Kamat, A. M., Shore, N. D., Meeks, J. J., Galsky, M. D., Jacob, J. M., van der Heijden, M. S., Williams, S. B., Powles, T., Chang, S. S., Catto, J. W. F., Psutka, S. P., Guerrero-Ramos, F., Xylinas, E., Miyake, M., Simone, G., Daniel, K., Sweiti, H., Cutie, C. & Necchi, A., 2025, (Accepted/In press) In: Urologic Oncology: Seminars and Original Investigations.Research output: Contribution to journal › Review article › peer-review
Open Access -
Perioperative Durvalumab in Bladder Cancer. Reply
Powles, T., Galsky, M. D. & van der Heijden, M. S., 6 Feb 2025, In: New England Journal of Medicine. 392, 6, p. 619 1 p.Research output: Contribution to journal › Letter › peer-review
Press/Media
-
Imfinzi approval a ‘breakthrough’ for muscle-invasive bladder cancer
2/04/25
1 item of Media coverage
Press/Media
-
Reports Outline Prostate Cancer Findings from Icahn School of Medicine at Mount Sinai [The Association of Statin Use With Survival Outcomes In Patients With Metastatic Castration-resistant Prostate Cancer (Mcrpc) Treated With Androgen Receptor ...]
Galsky, M., Liaw, B., Ganta, T. & Oh, W.
29/11/24
1 item of Media coverage
Press/Media
-
Prince Mario-Max Schaumburg-Lippe: Kindness Has A Name – Mike Rawls and Dr. Samuel Waxman’s Dedication To Support Samuel Waxman Cancer Research Foundation!
27/11/24
1 item of Media coverage
Press/Media